2017-2018 Session
Change SessionH.713
An act relating to prohibiting price gouging for essential off-patent or generic drugs
- Sponsor(s)
- Location
- House Committee on Health Care
- Last Recorded Action
- House 1/25/2018 - Read First Time and Referred to the Committee on Health Care
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Detailed Status
2017-2018 Legislative Session
| Body | Date | Journal | Calendar | Location | Full Status |
|---|
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Roll Call History
2017-2018 Legislative Session
| Body | Date | Journal | Location | Full Status |
|---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Committee Meetings
2017-2018 Legislative Session
| Meeting Date | Committee |
|---|
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Meeting Full List
2017-2018 Legislative Session
Wednesday, March 28, 2018
- Committee(s):
- House Committee on Health Care
- 11:30 AM
-
H.713 - An act relating to prohibiting price gouging for essential off-patent or generic drugs
Walk-through of these two prescription drug bills
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, March 29, 2018
- Committee(s):
- House Committee on Health Care
- 10:00 AM
-
H.713 - An act relating to prohibiting price gouging for essential off-patent or generic drugs
Concerns of Committee members re messages and advertisements about the bill
Bridget Morris, Lobbyist, Association for Accessible Medicines
Committee Documents
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Witnesses Who Testified
2017-2018 Legislative Session
House Committee on Health Care
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Bridget Morris, Lobbyist, Association for Accessible Medicines
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for H.713 in the 2017-2018 Legislative Session.
No committee of conference members found for H.713 in the 2017-2018 Legislative Session.
An act relating to prohibiting price gouging for essential off-patent or generic drugs
Committee of Conference Meetings
2017-2018 Legislative Session
| Meeting Date | Committee |
|---|
